Literature DB >> 19487391

Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia.

Mary C Clarke1, Antti Tanskanen, Matti Huttunen, John C Whittaker, Mary Cannon.   

Abstract

OBJECTIVE: The authors sought to determine whether prenatal exposure to infection and a positive family history of psychotic disorders interact synergistically to increase the risk of later developing schizophrenia.
METHOD: The authors linked two national registers, the Medical Birth Register and the Finnish Population Register, to identify all women in Helsinki who received hospital treatment during pregnancy for an upper urinary tract infection (N=9,596) between 1947 and 1990. The Finnish Hospital Discharge Register was used to ascertain psychiatric outcomes in adulthood of offspring exposed to infection prenatally. Family history of psychotic disorders was determined by linking the Hospital Discharge Register and the Population Register. The authors used an additive statistical interaction model to calculate the amount of biological synergism between positive family history and prenatal exposure to infection.
RESULTS: Prenatal exposure to infection did not significantly increase the risk of schizophrenia. However, the effect of prenatal exposure to pyelonephritis was five times greater in those who had a family history of psychosis compared to those who did not. The synergy analysis suggested that an estimated 38%-46% of the offspring who developed schizophrenia and had both prenatal exposure to infection and a positive family history of psychotic disorders did so as a result of the synergistic action of both risk factors.
CONCLUSIONS: These findings support a mechanism of gene-environment interaction in the causation of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487391     DOI: 10.1176/appi.ajp.2009.08010031

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  69 in total

1.  Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood.

Authors:  Philip R Nielsen; Thomas M Laursen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

3.  Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

Authors:  Deanna L. Kelly; Haley K. Demyanovich; Katrina M. Rodriguez; Daniela Ciháková; Monica V. Talor; Robert P. McMahon; Charles M. Richardson; Gopal Vyas; Heather A. Adams; Sharon M. August; Alessio Fasano; Nicola G. Cascella; Stephanie M. Feldman; Fang Liu; MacKenzie A. Sayer; Megan M. Powell; Heidi J. Wehring; Robert W. Buchanan; James M. Gold; William T. Carpenter; William W. Eaton
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

4.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

Review 5.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

6.  Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.

Authors:  Charles V Vorhees; Devon L Graham; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Neil M Richtand; Michael T Williams
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

7.  Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.

Authors:  Sarah Canetta; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Jaana Leiviskä; Christoph Kellendonk; Ian W McKeague; Alan S Brown
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

Review 8.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.

Authors:  Conrad Iyegbe; Desmond Campbell; Amy Butler; Olesya Ajnakina; Pak Sham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-17       Impact factor: 4.328

9.  Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy.

Authors:  Robert Freedman; Sharon K Hunter; M Camille Hoffman
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

Review 10.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.